版本:
中国

BRIEF-Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28

May 2 Ritter Pharmaceuticals Inc :

* Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28, and provides an update on its path forward into Phase 3

* Will be holding an end of Phase 2 meeting with FDA to present and discuss Phase 3 plan for RP-G28 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐